The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PKA signaling is associated with cardiomyocyte hypertrophy 84”
From Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A (2023) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Predicting effective microRNA target sites in mammalian mRNAs
Agarwal, V., Bell, G. W., Nam, J.-W., & Bartel, D. P. (2015) · eLife · doi:10.7554/elife.05005 · Cited by 7,318
miRBase: from microRNA sequences to function
Kozomara, A., Birgaoanu, M., & Griffiths-Jones, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1141 · Cited by 4,843
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781
Disruption of Fusion Results in Mitochondrial Heterogeneity and Dysfunction
Chen, H., Chomyn, A., & Chan, D. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503062200 · Cited by 1,376
Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission.
Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., & Mihara, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607279200 · Cited by 1,226
Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria
Cereghetti, G. M., Stangherlin, A., de Brito, O. M., Chang, C. R., Blackstone, C., Bernardi, P., & Scorrano, L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808249105 · Cited by 1,129
Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
Ong, S.-B., Subrayan, S., Lim, S. Y., Yellon, D. M., Davidson, S. M., & Hausenloy, D. J. (2010) · Circulation · doi:10.1161/circulationaha.109.906610 · Cited by 986
Cunningham, F., Achuthan, P., Akanni, W., Allen, J., Amode, M. R., Armean, I. M., Bennett, R., Bhai, J., Billis, K., Boddu, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1113 · Cited by 925
Mitochondrial bioenergetics and structural network organization
Benard, G., Bellance, N., James, D., Parrone, P., Fernandez, H., Letellier, T., & Rossignol, R. (2007) · Journal of Cell Science · doi:10.1242/jcs.03381 · Cited by 618
Research works printed but not linked: 63
- Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensin-converting enzyme–related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:1–9. · DOI · Paper page
- Ocaranza P, Godoy I, Jalil JE, Varas M, Collantes P, Pinto M, et al. Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension. 2006;572–8. · DOI · Paper page
- Ocaranza MP, Lavandero S, Jalil JE, Moya J, Pinto M, Novoa U, et al. Angiotensin-(1–9) regulates cardiac hypertrophy in vivo and in vitro. J Hypertens. 2010;28:1054–64. · DOI
- Ocaranza P, Rivera P, Novoa U, Pinto M, Gonza L, Chiong M, et al. Rho kinase inhibition activates the homologous angiotensin- converting enzyme-angiotensin-(1–9) axis in experimental hypertension. J Hypertens. 2011;29:706–15. · DOI
- Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, et al. Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension. 2012;59:300–7. · DOI
- Flores-Muñoz M, Smith NJ, Haggerty C, Milligan G, Nicklin SA. Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor. J Physiol. 2011;4:939–51. · DOI
- Fattah C, Nather K, McCarroll CS, Hortigon-Vinagre MP, Zamora V, Flores-Munoz M, et al. gene therapy with angiotensin-(1-9) preserves left ventricular systolic function after myocardial infarction. J Am Coll Cardiol. 2016;68:2652–66. · DOI
- Xu H, Zhang Y, Sun J, Wei J, Sun L, Zhang J. Effect of distinct sources of Ca2+ on cardiac hypertrophy in cardiomyocytes. Exp Biol Med. (Maywood). 2012;237:271–8. · doi:10.1258/ebm.2011.011273
- Shimizu I, Minamino T. Physiological and pathological cardiac hypertrophy. J Mol Cell Cardiol. 2016;97:245–62. · DOI · Paper page
- Pennanen C, Parra V, Lopez-Crisosto C, Morales PE, Del Campo A, Gutierrez T, et al. Mitochondrial fission is required for cardiomyocyte hypertrophy via a Ca2+ -calcineurin signalling pathway. J Cell Sci. 2014;127:1–33. · DOI
- Houser SR, Molkentin JD. Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal. 2008;1:1–7. · DOI
- Gutiérrez T, Parra V, Troncoso R, Pennanen C, Contreras-Ferrat A, Vasquez-Trincado C, et al. Alteration in mitochondrial Ca2+ uptake disrupts insulin signaling in hypertrophic cardiomyocytes. Cell Commun Signal. 2014;12:1–14. · DOI
- López-Crisosto C, Bravo-Sagua R, Rodriguez-Peña M, Mera C, Castro PF, Quest AFG, et al. ER-to-mitochondria miscommunication and metabolic diseases. Biochim Biophys Acta. 2015;1852:2096–105. · DOI
- Bartel DP, Lee R, Feinbaum R. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97. · DOI
- Hwang H, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer. 2007;94:776–80. · DOI · Paper page
- Lau NC, Lim LP, Weinstein EG, Bartel DP, Lau NC, Lim LP, et al. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 2001;294:858–62. · DOI · Paper page
- Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 2000;408:1998–2001. · DOI · Paper page
- Wu X, Piper-Hunter MG, Crawford M, Nuovo GJ, Clay B, Otterson GA, et al. Micrornas in the pathogenesis of lung cancer. J Thorac Oncol. 2009;4:1028–34. · DOI
- Yang B, Lu Y, Wang Z. MicroRNAs and apoptosis: implications in the molecular therapy of human disease. Clin Exp Pharm Physiol. 2009;36:951–60. · DOI
- Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, et al. Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets. Cardiovasc Hematol Agents Med Chem. 2009;7:82–90. · DOI
- Galasso M, Sana ME, Volinia S. Non-coding RNAs: a key to future personalized molecular therapy? Genome Med. 2010;2:1–10. · DOI
- Van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA. 2006;103:18255–60. · DOI · Paper page
- Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, et al. MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation. 2010;122:2378–87. · DOI · Paper page
- Parra V, Eisner V, Chiong M, Criollo A, Moraga F, Jaimovich E, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc Res. 2008;77:387–97. · DOI · Paper page
- Parra V, Verdejo HE, Iglewski M, Del Campo A, Troncoso R, Jones D, et al. Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFkB-Opa-1 signaling pathway. Diabetes. 2014;63:75–88. · DOI · Paper page
- Yu T, Sheu S-S, Robotham JL, Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res. 2008;79:341–51. · DOI · Paper page
- Munoz JP, Chiong M, García L, Troncoso R, Toro B, Pedrozo Z, et al. Iron induces protection and necrosis in cultured cardiomyocytes: role of reactive oxygen species and nitric oxide. Free Radic Biol Med. 2010;48:526–34. · DOI
- Contreras-Ferrat A, Toro B, Bravo-Sagua R, Parra V, Vasquez-Trincado C, Ibarra C, et al. An Inositol 1,4,5-triphosphate (IP3)-IP3 receptor pathway is required for insulin-stimulated glucose transporter 4 translocation and glucose uptake in cardiomyocytes. Endocrinology. 2010;151:4665–77. · DOI
- Chiong M, Parra V, Eisner V, Ibarra C, Maldonado C, Criollo A, et al. Parallel activation of Ca2+-induced survival and death pathways in cardiomyocytes by sorbitol-induced hyperosmotic stress. Apoptosis. 2010;15:887–903. · DOI
- Rojas-Rivera D, Díaz-Elizondo J, Parra V, Salas D, Contreras A, Toro B, et al. Regulatory volume decrease in cardiomyocytes is modulated by calcium influx and reactive oxygen species. FEBS Lett. 2009;583:3485–92. · DOI
- Bravo-Sagua R, López-Crisosto C, Parra V, Rodriguez M, Rothermel BA, Quest AFG, et al. mTORC1 inhibitor rapamycin and ER stressor tunicamycin induce differential patterns of ER- mitochondria coupling. Sci Rep. 2016;6:1–12. · DOI
- Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993;169:375–82. · DOI · Paper page
- Parra V, Altamirano F, Hernandez-Fuentes CP, Tong D, Kyrychenko V, Rotter D, et al. Down syndrome critical region 1 gene, rcan1, helps maintain a more fused mitochondrial network. Circ Res. 2018;122:1–26. · DOI
- Benes V, Collier P, Kordes C, Stolte J, Rausch T, Muckentaler MU, et al. Identification of cytokine- induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. Sci Rep. 2015;5:1–14. · DOI
- Hasler D, Lehmann G, Murakawa Y, Rajewsky N, Landthaler M, Meister G, et al. The lupus autoantigen La prevents Mis-channeling of t-RNA fragments into the human microRNA pathway. Mol Cell. 2016;63:110–24. · DOI
- Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 2014;30:2114–20. · DOI · Paper page
- Orell A, Tripp V, Aliaga-Tobar V, Albers S, Maracaja-Coutinho V, Randau L. A regulatory RNA is involved in RNA duplex formation and biofilm regulation in Sulfolobus acidocaldarius. Nucleic Acids Res. 2018;46:4794–806. · doi:10.1093/nar/gky144
- Matamala JM, Arias-Carrasco R, Sanchez C, Uhrig M, Matus S, Maracaja-Coutinho V, et al. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis. Neurobiol Aging. 2018;64:123–38. · DOI
- Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, et al. The Ensembl genome database project. Nucleic Acids Res. 2002;30:38–41. · DOI · Paper page
- Langmead B. Aligning short sequencing reads with Bowtie. Curr Protoc Bioinforma. 2010;11:1–24.
- Quinlan AR. BEDTools: the Swiss-army tool for genome feature analysis. Curr Protoc Bioinforma. 2015;47:12.1–12.34.
- Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res. 2012;40:9850–62. · DOI · Paper page
- Pall GS, Hamilton AJ. Improved northern blot method for enhanced detection of small RNA. Nat Protoc. 2008;3:1077–84. · DOI · Paper page
- Nam J, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2015;53:1031–43. · DOI · Paper page
- Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12:697. · DOI · Paper page
- Ocaranza MP, Moya J, Barrientos V, Alzamora R, Hevia D, Morales C, et al. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis. J Hypertens. 2014;32:771–83. · DOI
- Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264:224–34. · DOI · Paper page
- Yoon Y, Krueger EW, Oswald BJ, Mcniven MA. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol. 2003;23:5409–20. · DOI · Paper page
- Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulatesmitochondrial fission and cell death. EMBO Rep. 2007;8:939–44. · DOI · Paper page
- Chang C-R, Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of drp1 regulates its gtpase activity and mitochondrial morphology. J Biol Chem. 2007;282:21583–7. · DOI · Paper page
- Santel A, Frank S. Shaping mitochondria: the complex posttranslational regulation of the mitochondrial fission protein DRP1. IUBMB Life. 2008;60:448–55. · DOI
- Eisner V, Parra V, Lavandero S, Hidalgo C, Jaimovich E. Mitochondria fine-tune the slow Ca2+ transients induced by electrical stimulation of skeletal myotubes. Cell Calcium. 2010;48:358–70. · DOI
- Rothermel BA, Vega RB, Williams RS. The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med. 2003;13:15–21. · DOI · Paper page
- Giorgi C, De Stefani D, Bononi A, Rizzuto R, Pinton P. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol. 2010;41:1817–27. · DOI · Paper page
- Bravo-Sagua R, Parra V, Ortiz-Sandoval C, Navarro-Marquez M, Rodriguez AE, Díaz-Valdivia N, et al. Caveolin-1 impairs PKA-DRP1-mediated remodelling of ER–mitochondria communication during the early phase of ER stress. Cell Death Differ. 2019;1:1195–212. · DOI
- Ding J, Li X, Hu H. TarPmiR: a new approach for microRNA target site prediction. Bioinformatics. 2016;32:2768–75. · DOI · Paper page
- Olsen SR, Uhler MD. Inhibition of protein kinase-A by overexpression of the cloned human protein kinase inhibitor. Mol Endocrinol. 1991;5:1246–56. · DOI
- Vásquez-Trincado C, García-Carvajal I, Pennanen C, Parra V, Hill JA, Rothermel BA, et al. Mitochondrial dynamics, mitophagy and cardiovascular disease. J Physiol. 2016;3:509–25. · DOI · Paper page
- Chen Y, Liu Y, Dorn GW II. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res. 2011;109:1327–31. · DOI · Paper page
- Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V, et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc. 2012;1:1–12. · DOI · Paper page
- Ashrafian H, Docherty L, Leo V, Towlson C, Neilan M, Lygate CA, et al. A Mutation in the mitochondrial fission gene dnm1l leads to cardiomyopathy. Plos Genet. 2010;6:1–18. · DOI
- Givvimani S, Munjal C, Tyagi N, Sen U, Metreveli N, Tyagi SC. Mitochondrial division/mitophagy inhibitor (mdivi) ameliorates pressure overload induced heart failure. PLoS ONE. 2012;7:e32388. · DOI · Paper page
- Jeppesen PL, Christensen GL, Mikael S, Yaël Nossent A, Jensen Bronnum H, Andersen DC, et al. Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. Br J Pharm. 2011;164:394–404. · DOI
Cited by
Drp1-dependent mitochondrial fission in cardiovascular disease
Jin, J.-Y., Wei, X.-X., Zhi, X.-L., Wang, X.-H., & Meng, D. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00518-y · Cited by 386
SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
Fenrich, M., Mrdenovic, S., Balog, M., Tomic, S., Zjalic, M., Roncevic, A., Mandic, D., Debeljak, Z., & Heffer, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00229 · Cited by 95
Edmond Fischer's kinase legacy: History of the protein kinase inhibitor and protein kinase A
Taylor, S. S., Herberg, F. W., Veglia, G., & Wu, J. (2023) · IUBMB Life · doi:10.1002/iub.2714 · Cited by 15
Metadata
- Authors
- Sotomayor-Flores, C., Rivera-Mejías, P., Vásquez-Trincado, C., López-Crisosto, C., Morales, P. E., Pennanen, C., Polakovicova, I., Aliaga-Tobar, V., García, L., Roa, J. C., Rothermel, B. A., Maracaja-Coutinho, V., Ho-Xuan, H., Meister, G., Chiong, M., Ocaranza, M. P., Corvalán, A. H., Parra, V., & Lavandero, S.
- ORCID
- Sotomayor-Flores, Cristian
- Rivera-Mejías, Pablo
- Vásquez-Trincado, César
- López-Crisosto, Camila
- Morales, Pablo E.
- Polakovicova, Iva
- Aliaga-Tobar, Víctor
- García, Lorena
- Roa, Juan Carlos
- Rothermel, Beverly A.
- Maracaja-Coutinho, Vinicius
- Ho-Xuan, Hung
- Chiong, Mario
- Ocaranza, María Paz
- Corvalán, Alejandro H.
- Parra, Valentina
- Lavandero, Sergio
- Venue
- Cell Death & Differentiation
- Published
- 2020-03-09
- Volume
- 27
- Issue
- 9
- Pages
- 2586-2604
- ISSN
- 1350-9047
- 1476-5403
- Cited by
- 49
- References
- 13
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway. https://app.cochat.ai/papers/10.1038/s41418-020-0522-3
- The paper
- Sotomayor-Flores, C., Rivera-Mejías, P., Vásquez-Trincado, C., López-Crisosto, C., Morales, P. E., Pennanen, C., Polakovicova, I., Aliaga-Tobar, V., García, L., Roa, J. C., Rothermel, B. A., Maracaja-Coutinho, V., Ho-Xuan, H., Meister, G., Chiong, M., Ocaranza, M. P., Corvalán, A. H., Parra, V., & Lavandero, S. (2020). Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway. Cell Death & Differentiation. https://doi.org/10.1038/s41418-020-0522-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.